These findings indicate that CAMKKβ plays an oncogenic role in this setting and that CAMKKβ and AMPK-β1 play opposing roles in Pten-deficient prostate cancer, possibly reflecting their differential regulation of lipogenesis [210]. Here, CAMKK2 is linked to prostate carcinoma.